pembrolizumab,bevacizumab
merck,roche
[' bev ', 'keynote-826', 'gyn', 'pembro']
#asco23: updated keynote-826 findings support use of pembro+chemo with or w/out bev as a new standard of care for patients with persistent, recurrent, or metastatic #cervicalcancer: #ascodailynews #gynonc 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.